Anushka Dongre

8PUBLICATIONS
34CO-AUTHORS
Cancer diagnosisMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 06, 2026
Epithelial-mesenchymal transition and immunosuppression: Two sides of the same coin.

|May 20, 2026
NRF2 activation by myeloid cell-derived oxidative stress induces SNAI-driven features of EMT in breast cancer.

|May 12, 2026
CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy.

|Jan 22, 2026
Epithelial-mesenchymal plasticity and immunosuppression in canine carcinomas reveals cross-species upregulation of CD109.

Kimaya Bakhle, Sophie Nelissen, Lynna Li

|Jun 04, 2025
CD4+ T-cells sensitize quasi-mesenchymal breast tumors lacking CD73 to anti-CTLA4 immune checkpoint blockade therapy.

Shiney Chandraganti, Caitlyn Sams, Sarthak Sahoo

|May 16, 2023
Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial-Mesenchymal Transition.

Isabel O'Connell, Anushka Dongre

Pageof 2

Frequent Collaborators

2 joint publications

Shiney Chandraganti

2 joint publications

Brian Feng

2 joint publications

Kimaya Bakhle

1 joint publications

Mohammad Rashidian